Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIOren Study of pioglitazone versus placebo added to insulin in type 2 diabetes with dialysis-dependent renal failure
2007-006744-21Phase 2Completed
- Sponsor
- Takeda
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Pioglitazone + standard insulin with Placebo + standard insulin (2 arms). Primary endpoint: Change in total daily insulin dose. Started May 2008; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-006744-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006744-21.